What is HUMA's current stock price?

As of now, HUMA is trading at $1.23, with a daily change of +3.24%.

What are the risks associated with HUMA stock?

HUMA Key risk is its Extreme, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

HUMA Stock Analysis & IQ Rating | Humacyte

HUMA

Humacyte

$1.23

+$0.04 | +3.24%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

TopRated 01:33 PM

continues to impress, rising 20% over the past year on iPhone 17 momentum, Mac and iPad upgrades, and a strong push in Services. Even with valuation concerns, Apple’s ability to innovate keeps investors wondering if ther...

HUMA Stock IQ

Login to see Humacyte (HUMA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

HUMA Target Price

Login to display

Strengths

HUMA Rewards

Upgraded on attractively valued

Chart

$1.72 (-28.49%)

$1.54 (-20.13%)

$2.19 (-43.84%)

$4.4 (-72.05%)

1year

6month

3month

1month

HUMA Risk Level

HUMA has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Extreme

LOW

HIGH

HUMA Analysts Opinion

HUMA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

HUMA Analysts Opinion

HUMA Analysts opinion is negative but has improved from the past 3 months

HUMA Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

45%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

NA

HUMA Street Sentiment

HUMA Street Sentiment is unimpressive and have negative views on the near-term outlook

HUMA Performance Sentiment

Sentiments overview associated with HUMA events and the stock performance.

45%

Positive

Negative

5 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$1.25

Resistance
Price

$1.25

Current Price Range

$2.48

Show methods +

HUMA Latest Analysis +

Benchmark Maintains Humacyte (HUMA) Buy Recommendation. Fintel reports that on November 13 2025 Benchmark maintained coverage of Humacyte (NasdaqGS:HUMA) with a Buy recommendation. Analyst Price Forecast Suggests 622.45% Upside

Today

$1.23 | +3.24%

Rating

Humacyte Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript. Humacyte Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript November 12 2025 Humacyte Inc. beats earnings expectations. Reported EPS is $-0.14 expectations were $-0.17. Operator: Good morning ladies and gentlemen and welcome to the Humacyte’.s Third Quarter Results Conference Call. [Operator Instructions] As a reminder this conference call is being recorded. I’.ll now turn the call [….]

Thu Nov 13, 2025

$1.19 | -4.80%

Earnings

D. Boral Capital Maintains Humacyte (HUMA) Buy Recommendation. Fintel reports that on November 12 2025 D. Boral Capital maintained coverage of Humacyte (NasdaqGS:HUMA) with a Buy recommendation. Analyst Price Forecast Suggests 590.54% Upside

Thu Nov 13, 2025

$1.19 | -4.80%

Rating

Humacyte outlines 12-month cash runway and accelerates Symvess adoption following $56.5M capital raise.

Wed Nov 12, 2025

$1.25 | -2.73%

Activity

Humacyte Inc. (HUMA) Reports Q3 Loss Misses Revenue Estimates. Humacyte Inc. (HUMA) delivered earnings and revenue surprises of 17.65% and -17.71% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Wed Nov 12, 2025

$1.25 | -2.73%

Earnings

Humacyte GAAP EPS of -$0.11 beats by $0.05 revenue of $0.75M misses by $0.17M.

Wed Nov 12, 2025

$1.25 | -2.73%

Earnings

Earnings Scheduled For November 12 2025. . Hudbay Minerals (NYSE:HBM) is projected to report quarterly earnings at $0.07 per share on revenue of $411.46 million. . European Wax Center (NASDAQ:) is estimated to report quarterly earnings at $0.11 per share on revenue of $52.59 million. . Boyd Group Services (NYSE:BGSI) is projected to report quarterly earnings at $0.66 per share on revenue of $792.07 million. . Katapult Holdings (NASDAQ:KPLT) is expected to report quarterly loss at $0.21 per share

Wed Nov 12, 2025

$1.25 | -2.73%

Earnings

D. Boral Capital Maintains Humacyte (HUMA) Buy Recommendation. Fintel reports that on November 10 2025 D. Boral Capital maintained coverage of Humacyte (NasdaqGS:HUMA) with a Buy recommendation. Analyst Price Forecast Suggests 541.58% Upside

Tue Nov 11, 2025

$1.29 | -5.19%

Rating

FAQ About HUMA Stock Insights

What is HUMA current stock price?

What are HUMA stock strengths?

What risks are associated with HUMA stock?

When is HUMA next earnings report?

What is HUMA market cap and volume?

What is HUMA's current Stock IQ?

Should I buy HUMA stock right now?

Is HUMA a Strong Buy right now?

What does a 'Strong Buy' rating mean for HUMA?

What does a 'Strong Sell' rating mean for HUMA?

What factors influence HUMA's Stock IQ?

Explore our HUMA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored HUMA Stock Strategies
Effective Risk Management

FIND US ON

Receive our HUMA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

HUMA

Humacyte

Current Price

$1.23

+$0.04 | +3.24%

52W High

$ 6.77

MKT CAP

$ 228.47M

52W Low

$ 1.13

VOL

$ 5.54M

P/E Ratio

N/A

AVG VOL

$ 6.91M

RSI

34.09

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

HUMA Rewards

Upgraded on attractively valued

HUMA Stock IQ

Login to unlock Humacyte (HUMA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$1.72 (-28.49%)

$1.54 (-20.13%)

$2.19 (-43.84%)

$4.4 (-72.05%)

1year

6month

3month

1month

HUMA Analysts Opinion

HUMA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

HUMA Analysts Opinion

HUMA Analysts opinion is negative but has improved from the past 3 months

HUMA Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

45%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

NA

HUMA Street Sentiment

HUMA Street Sentiment is unimpressive and have negative views on the near-term outlook

HUMA Risk Level

HUMA has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Extreme

LOW

HIGH

HUMA Performance Sentiment

Sentiments overview associated with HUMA events and the stock performance.

45%

Positive

Negative

5 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$1.25

Resistance
Price

$1.25

Current Price Range

$2.48

Show methods +

HUMA Latest Analysis

TopRated 01:33 PM

continues to impress, rising 20% over the past year on iPhone 17 momentum, Mac and iPad upgrades, and a strong push in Services. Even with valuation concerns, Apple’s ability to innovate keeps investors wondering if ther...

Discover HUMA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HUMA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our HUMA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

HUMA Stock trends

HUMA Stock performance

HUMA Stock analysis

HUMA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing HUMA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing HUMA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

HUMA Stock Analysis & IQ Rating | Humacyte

HUMA Stock IQ

HUMA Target Price

HUMA Risk Level

HUMA Analysts Opinion

HUMA Street Sentiment

HUMA Performance Sentiment

Technical Price Levels

Explore our HUMA Stock insights

Receive our HUMA Daily Alerts

HUMA Stock IQ

HUMA Street Sentiment

HUMA Risk Level

Technical Price Levels

Discover HUMA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HUMA. We're here to help you make informed investment decisions today.

Receive our HUMA Daily Alerts

HUMA Runner Alarm